Gildan Activewear 21% Drop|Short-Sellers 18% Hit or Hanes Integration Dip?

The Short Report That Took 19 Cents off Every Dollar

Gildan Activewear fell 18.8% on June 16 in a single session, closing at $50.35 after Jehoshaphat Research released a 60-page short-seller report alleging the company has been stuffing distribution channels to inflate revenue growth. The firm holds a 4% short position in Gildan's float and named the same tactic it used to call Goeasy's eventual 80% collapse. That track record is why the market did not dismiss the report as noise. The provisional answer to why the drop happened is narrow: the channel-stuffing claim, if true, means Gildan's revenue trajectory for the second half of 2026 is front-loaded demand that already sold, not new demand yet to come.

What makes the drop genuinely unresolvable is not the short position but the rebuttal. Bank of Nova Scotia analyst John Zamparo reduced his price target to US$65 from US$72 — acknowledging near-term uncertainty — but held his stance, arguing that Gildan's core thesis never rested on top-line growth. His point is precise: the investment case is margin expansion and cash generation from the HanesBrands acquisition, not organic revenue momentum. If he is right, Jehoshaphat's channel concern is aimed at a metric the bull case does not require.

That is the paralysis. The bear and the bull are both responding to the same fact — Gildan's revenue recognition — and arriving at completely different assessments of what it means for the stock. The viewer cannot resolve this from the outside; the data that decides it sits inside Gildan's Q2 books, which have not been published.

Channel Stuffing and the Off-Balance-Sheet Receivables Claim

Jehoshaphat's core accusation has two connected parts. The first is channel stuffing: Gildan has been pushing inventory into distribution beyond actual consumer sell-through, which accelerates recognized revenue today at the cost of future orders. The second is the mechanism that enables it at scale: the firm alleges that Gildan transfers almost half of its receivables off-balance-sheet, which obscures the true inventory build in the channel from standard balance-sheet screening tools.

This is the buried assumption the bull case requires to be false. Every synergy calculation, every free cash flow forecast, and every earnings-per-share projection that underpins the 10.6x forward P/E multiple assumes that the revenue base being compounded is real demand from end consumers, not borrowed demand from a strained distribution channel. If the receivables transfer is as large as Jehoshaphat claims, the traditional metrics available to analysts and retail investors do not fully capture the channel load.

Gildan's official response was terse: the company said it is confident its disclosure is accurate and declined further comment. That is not an unusual response to a short-seller attack, but it is not a refutation either. The company did not publish counter-data on channel inventory levels, sell-through rates, or receivables composition. The silence leaves the accounting claim standing as an open question, which is exactly the condition that sustains the investor paralysis.

The reversal card here is the identity of the accuser. Jehoshaphat is not a hedge fund with an anonymous thesis. This is the firm that published on Goeasy before that stock lost 80% of its value over nine months. The market knows this, which is why an 18.8% single-day drop — not a 3% or 5% reaction — followed the report within hours.

HanesBrands Synergy Timeline vs. Channel Drain Risk

The tension sharpens when management's own guidance is set beside the short thesis. Gildan closed the HanesBrands acquisition on December 1, 2025, adding a scale that brings full-year 2026 revenue guidance to $6.0 to $6.2 billion — roughly double the pre-acquisition run rate. Management raised the three-year cost synergy target to $250 million from $200 million, with $100 million expected to land in 2026 alone. Free cash flow is projected at over $850 million in 2026 and above $1 billion in 2028.

These numbers are what make the short thesis consequential rather than merely embarrassing. If channel stuffing is pulling 2026 sales forward from 2027, the synergy math does not change — but the revenue base compounding those synergies does. A company guiding for $6.1 billion in revenue that is partially inflated carries a different valuation multiple than one where $6.1 billion represents clean, sustainable demand. The stock at 10.6x forward earnings looks like deep value if earnings hold; it does not look like deep value if the forward revenue assumption is overstated by one or two quarters of channel drain.

The verification anchor is Q2 2026 earnings, expected in late July or early August. That report will be the first period in which Jehoshaphat's channel-drain prediction is testable against actual sell-through data and restated channel inventory levels. Holders should watch whether Q2 revenue comes in below the run-rate implied by the HanesBrands integration guidance — a miss accompanied by distributor inventory normalization commentary would validate the short thesis. Watch-list candidates should watch whether Gildan provides granular receivables disclosure voluntarily in Q2, given the off-balance-sheet accusation is now public. A company confident in its accounting typically responds to a specific accounting allegation with specific accounting data. The persistent risk for the bull case is that Q2 guidance holds but the receivables question goes unanswered — leaving the unresolved accounting question to reprice the stock again ahead of Q3, regardless of whether the quarter itself beats or misses.